Genistein caused dose- and time-dependent increases in BRCA1 and BRCA2 protein levels in two oestrogen-responsive breast cancer cell lines (MCF-7 and T47D) (Figure 3D). This evidence concerns the gene BRCA2 and breast carcinoma.